Developmental effects of dietary n-3 fatty acids on activity and response to novelty

Physiology and Behavior

Volumn 101, Issue 1, 2010, Pages 176-183

  Levant, Beth ^a,b   Zarcone, Troy J ^c   Fowler, Stephen C ^d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

Brain; Docosahexaenoic acid; Force plate actometer; Habituation; Locomotor activity; Novelty; Omega 3; Polyunsaturated fatty acid; Rat

Indexed keywords

LINOLEIC ACID; PHOSPHOLIPID; DOCOSAHEXAENOIC ACID; FAT INTAKE; LINOLENIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BODY MOVEMENT; BRAIN FUNCTION; BRAIN TISSUE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HABITUATION; LIPID BRAIN LEVEL; LONG EVANS RAT; MALE; MATERNAL NUTRITION; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; FAT INTAKE; GROWTH, DEVELOPMENT AND AGING; LEARNING; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY;

ALPHA-LINOLENIC ACID; ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DIETARY FATS; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS;

EID: 77953915709     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.04.038     Document Type: Article

References (53)

1. Lavigne J.V., Gibbons R.D., Christoffel K.K., Arend R., Rosenbaum D., Binns H., et al. Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry 1996, 35:204-214.
2. Skjoldager P., Fowler S.C. Scopolamine attenuates the motor disruptions but not the attentional disturbances induced by haloperidol in a sustained attention task in the rat. Psychopharmacology (Berl) 1991, 105:93-100.
3. Brockel B., Fowler S. Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine. J Pharmacol Exp Ther 1995, 275:1090-1098.
4. Kornetsky C. The use of a simple test of attention as a measure of drug effects in schizophrenic patients. Psychopharmacologia 1972, 24:99-106.
5. Chee P., Gordon L., Schachar R., Lindsay P., Wachsmuth R. Effects of event rate and display time on sustained attention in hyperactive, normal, and control children. J Abnorm Child Psychol 1989, 17:371-391.
6. Taylor E. Clinical foundations of hyperactivity research. Behav Brain Res 1998, 94:11-24.
7. Porrino L.J., Rapoport J.L., Behar D., Ismond D.R., Bunney W.E. A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. Arch Gen Psychiatry 1983, 40:688-693.
8. Sagvolden T., Sergeant J.A. Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res 1998, 94:1-10.
9. Sleator E.K., Ullmann R.K. Can the physician diagnose hyperactivity in the office?. Pediatrics 1981, 67:13-17.
10. Fowler, S. C., Zarone, T. J., Levant, B. Methylphenidate attenuates rats' preference of a novel spatial stimulus introduced into a familiar environment: assessment using a force plate actometer. J. Neurosci. Meth, http://doi:10.1016/j.neumeth.2010.03.014.
11. Mitchell E.A., Aman M.G., Turbott S.H., Manku M.S. Clinical characteristics and serum fatty acid levels in hyperactive children. Clin Pediatr 1987, 26:406-411.
12. Burgess J.R., Stevens L., Zhang W., Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000, 71:327-330.
13. Stevens L., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R., et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995, 62:761-768.
14. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006, 75:299-308.
15. Colter A.L., Cutler C., Meckling K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 2008, 7:8.
16. Ross B.M., McKenzie I., Glen I., Bennett C.P. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 2003, 6:277-281.
17. Brookes K.J., Chen W., Xu X., Taylor E., Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 60:1053-1061.
18. McNamara R.K., Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 2006, 75:329-349.
19. Chalon S. The role of fatty acids in the treatment of ADHD. Neuropharmacology 2009, 57:636-639.
20. Schuchardt J.P., Huss M., Stauss-Grabo M., Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr 2009.
21. Raz R., Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 2009, 51:580-592.
22. Ozias M.K., Carlson S.E., Levant B. Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J Nutr 2007, 137:125-129.
23. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
24. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Voronstova E., Wang G., et al. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Meth 2001, 107:107-124.
25. Levant B., Ozias M.K., Jones K.A., Carlson S.E. Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain. Lipids 2006, 41:407-414.
26. Leussis M.P., Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 2006, 30:1045-1064.
27. Galli C., Trzeciak H.I., Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta 1971, 248:449-454.
28. Berlyne D.E. Arousal, reward and learning. Ann NY Acad Sci 1969, 159:1059-1070.
29. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 1983, 16:83-109.
30. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther 1995, 275:345-357.
31. Frantz K.J., Van Hartesveldt C. The locomotor effects of quinpirole in rats depend on age and gender. Pharmacol Biochem Behav 1999, 64:821-826.
32. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 2004, 152:49-57.
33. Levant B., Ozias M.K., Carlson S.E. Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats. Physiol Behav 2006, 89:196-204.
34. Vancassel S., Blondeau C., Lallemand S., Cador M., Linard A., Lavialle M., et al. Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex. Behav Brain Res 2007, 180:119-126.
35. Enslen M., Milon H., Malnoe A. Effect of low intake of n-3 fatty acids during development on brain phospholipid fatty acid composition and exploratory behavior in rats. Lipids 1991, 26:203-208.
36. Reisbick S., Neuringer M., Hasnain R., Connor W.E. Home cage behavior of rhesus monkeys with long-term deficiency of omega-3 fatty acids. Physiol Behav 1994, 55:231-239.
37. Bush G. Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology Reviews 2008, 10.1038/npp2009.120.
38. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 1996, 66:1582-1591.
39. Zimmer L., Delpal S., Guilloteau D., Aioun J., Durand G., Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 2000, 284:25-28.
40. Zimmer L., Durand G., Guilloteau D., Chalon S. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex. Lipids 1999, 34(Suppl):S251.
41. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., et al. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 1998, 240:177-181.
42. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 2002, 75:662-667.
43. Zimmer L., Delion S., Vancassel S., Durand G., Guilloteau D., Bodard S., et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 2000, 41:32-40.
44. Kuperstein F., Eilam R., Yavin E. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J Neurochem 2008, 106:662-671.
45. Ahmad S.O., Park J.H., Radel J.D., Levant B. Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci Lett 2008, 438:303-307.
46. Jeffrey B.G., Weisinger H.S., Neuringer M., Mitchell D.C. The role of docosahexaenoic acid in retinal function. Lipids 2001, 36:859-871.
47. Prusky G.T., Douglas R.M. Vision. The behavior of the laboratory rat 2005, 49-59. Oxford University Press, New York. I.Q. Whishaw, B. Kolb (Eds.).
48. Innis S.M. The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci 2000, 22:474-480.
49. Levant B., Ozias M.K., Carlson S.E. Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition. J Nutr 2006, 136:2236-2242.
50. Levant B., Ozias M.K., Carlson S.E. Diet (n-3) polyunsaturated fatty acid content and parity affect liver and erythrocyte phospholipid fatty acid composition in female rats. J Nutr 2007, 137:2425-2430.
51. Levant B., Ozias M.K., Davis P.F., Winter M., Russell K.L., Carlson S.E., et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008, 33:1279-1292.
52. Davis, P. F., Ozias, M. K., Carlson, S. E., Reed, G. A., Winter, M. K., McCarson, K. E., Levant, B. Dopamine receptor alterations in females rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr. Neurosci.in press.
53. Stark K.D., Lim S.Y., Salem N. Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid composition. J Lipid Res 2007, 48:2471-2477.